Piedmont Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-90,683
Closed -$12.6M 393
2020
Q1
$12.6M Buy
90,683
+11,178
+14% +$1.54M 0.5% 42
2019
Q4
$10.4M Buy
79,505
+2,677
+3% +$310K 0.36% 70
2019
Q3
$8.59M Buy
76,828
+911
+1% +$101K 0.33% 74
2019
Q2
$8.41M Buy
75,917
+2,860
+4% +$337K 0.34% 73
2019
Q1
$9.48M Sell
73,057
-78,671
-52% -$9.57M 0.38% 55
2018
Q4
$17.6M Sell
151,728
-11,176
-7% -$1.25M 0.84% 21
2018
Q3
$17.5M Sell
162,904
-6,319
-4% -$632K 0.73% 21
2018
Q2
$14.4M Sell
169,223
-63,420
-27% -$5.21M 0.7% 22
2018
Q1
$18M Sell
232,643
-79,975
-26% -$6.44M 0.48% 50
2017
Q4
$26.4M Sell
312,618
-1,796
-0.6% -$153K 0.53% 48
2017
Q3
$26.9M Buy
314,414
+65,602
+26% +$5.38M 0.57% 43
2017
Q2
$20.5M Sell
248,812
-34,308
-12% -$2.8M 0.45% 54
2017
Q1
$23.8M Buy
283,120
+47,985
+20% +$3.84M 0.49% 55
2016
Q4
$17.3M Buy
235,135
+19,019
+9% +$1.42M 0.36% 78
2016
Q3
$17.3M Sell
216,116
-20,760
-9% -$1.66M 0.38% 73
2016
Q2
$18.7M Buy
236,876
+2,020
+0.9% +$152K 0.38% 72
2016
Q1
$16.9M Buy
234,856
+3,110
+1% +$235K 0.36% 78
2015
Q4
$19.5M Buy
231,746
+1,910
+0.8% +$159K 0.41% 69
2015
Q3
$19.2M Buy
229,836
+1,715
+0.8% +$145K 0.43% 65
2015
Q2
$19M Buy
228,121
+143,957
+171% +$11M 0.4% 78
2015
Q1
$6.11M Sell
84,164
-278
-0.3% -$19.8K 0.37% 48
2014
Q4
$5.83M Sell
84,442
-532
-0.6% -$35.9K 0.35% 53
2014
Q3
$5.51M Sell
84,974
-222
-0.3% -$14.1K 0.29% 54
2014
Q2
$5.3M Sell
85,196
-187
-0.2% -$11.2K 0.28% 53
2014
Q1
$5.03M Sell
85,383
-12,517
-13% -$699K 0.28% 51
2013
Q4
$4.99M Buy
97,900
+826
+0.9% +$41.4K 0.27% 52
2013
Q3
$4.89M Buy
97,074
+12,015
+14% +$629K 0.26% 51
2013
Q2
$4.18M Buy
+85,059
New +$4.63M 0.19% 63

Other funds holding LLY

Piedmont Investment Advisors's LLY Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Eli Lilly (LLY) in Q2 2020, closing a stake of 90,683 shares — an estimated $12.6M sold.

Piedmont Investment Advisors first reported a position in LLY in Q2 2013 and held it in 28 quarters. The position peaked at $26.9M in Q3 2017. 1,764 funds tracked by Wall St. Rank hold LLY as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Eli Lilly position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 90,683 Eli Lilly shares in Q2 2020, an estimated $12.6M.
  • Piedmont Investment Advisors first reported a position in Eli Lilly in Q2 2013 and held it in 28 quarters.
  • Piedmont Investment Advisors's Eli Lilly position peaked at $26.9M in Q3 2017.
  • 1,764 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.